Research location
Sorocaba
Brazil
Advertisement
Research activity in Sorocaba
BrazilCureCurrent currently publishes aggregate city-level research activity for this location: 48 trials and 48 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sorocaba
48 linked trials · page 1 of 1A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaNCT07219173 · 2025-10-22 · 1 site observation
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsNCT06932263 · 2025-03-26 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseNCT06283966 · 2024-02-21 · 1 site observation
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaNCT06023589 · 2023-08-24 · 1 site observation
RECRUITING
An Ophthalmic Safety Study in Patients With Breast CancerNCT06767462 · 2025-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase III Long-Term Extension Study With DexpramipexoleNCT06388889 · 2024-06-12 · 1 site observation
TERMINATED
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaNCT05398263 · 2022-08-09 · 1 site observation
TERMINATED
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersNCT05152147 · 2021-12-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib FailureNCT04988295 · 2021-11-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)NCT04784715 · 2021-04-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)NCT04609904 · 2021-03-01 · 1 site observation
COMPLETED
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast CancerNCT04538742 · 2020-12-28 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 InsertionsNCT04538664 · 2020-10-13 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT04487080 · 2020-09-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)NCT04497844 · 2020-09-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerNCT04494425 · 2020-07-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsNCT04053634 · 2019-08-26 · 1 site observation
COMPLETED
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate CancerNCT03871816 · 2019-04-22 · 1 site observation
COMPLETED
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerNCT03748641 · 2019-01-25 · 1 site observation
ACTIVE_NOT_RECRUITING
BRazilian Asthmatics Patients EOSinophilic Profile (BRAEOS)NCT03925415 · 2019-01-24 · 1 site observation
COMPLETED
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled AsthmaNCT03706079 · 2019-01-07 · 1 site observation
COMPLETED
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaNCT03557307 · 2018-08-01 · 1 site observation
COMPLETED
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled AsthmaNCT03347279 · 2017-11-23 · 1 site observation
COMPLETED
Evaluation of Dupilumab in Children With Uncontrolled AsthmaNCT02948959 · 2017-04-21 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)NCT02727660 · 2016-04-29 · 1 site observation
COMPLETED
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCNCT02489318 · 2015-11-27 · 1 site observation
ACTIVE_NOT_RECRUITING
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASNCT02531516 · 2015-11-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Dupilumab in Patients With Severe Steroid Dependent AsthmaNCT02528214 · 2015-10-15 · 1 site observation
COMPLETED
Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung CancerNCT02272413 · 2015-07-08 · 1 site observation
COMPLETED
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)NCT02414854 · 2015-04-27 · 1 site observation
COMPLETED
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)NCT02395172 · 2015-03-24 · 1 site observation
COMPLETED
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With AsthmaNCT02224157 · 2014-11-28 · 1 site observation
COMPLETED
A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABANCT02258542 · 2014-11-19 · 1 site observation
COMPLETED
Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)NCT02134028 · 2014-08-05 · 1 site observation
COMPLETED
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.NCT02149199 · 2014-07-07 · 1 site observation
COMPLETED
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02155660 · 2014-06-25 · 1 site observation
COMPLETED
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled AsthmaNCT01928771 · 2013-09-19 · 1 site observation
COMPLETED
Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.NCT02472964 · 2012-07-01 · 1 site observation
COMPLETED
Effect of High Dose Ciclesonide on Asthma ControlNCT01455194 · 2011-11-01 · 1 site observation
COMPLETED
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyNCT00957554 · 2009-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment WithdrawalNCT00865020 · 2009-03-01 · 1 site observation
COMPLETED
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabNCT00625898 · 2008-04-01 · 1 site observation
TERMINATED
A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With RisperidoneNCT01010776 · 2008-02-01 · 1 site observation
COMPLETED
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerNCT00528567 · 2007-12-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.NCT00448591 · 2006-09-01 · 1 site observation
COMPLETED
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00949910 · 2004-11-01 · 1 site observation
COMPLETED
Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further TreatmentNCT00683306 · 1 site observation
APPROVED_FOR_MARKETING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.